Dynamic fibrinogen decline rate outperforms static admission values in predicting hematoma expansion in APL-related intracranial hemorrhage: a retrospective cohort study.
5 affiliations
- 1Department of Neurosurgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
- 2Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou, China.
- 3Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
- 4Department of Hematology, Ganzhou People's Hospital, Ganzhou, China.
- 5Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University, Ganzhou, China.
Abstract
Background
Intracranial hemorrhage (ICH) is the leading cause of early death in acute promyelocytic leukemia (APL). Current risk assessment relies on static coagulation parameters at admission, but APL-associated coagulopathy evolves rapidly. Whether dynamic changes in coagulation markers predict hematoma expansion remains unknown.Objective
To determine whether the fibrinogen decline rate and D-dimer increase rate predict hematoma expansion in APL-related ICH, and to compare their predictive performance with static admission values.Methods
This single-center retrospective cohort study included 68 APL patients with spontaneous ICH. Hematoma expansion was defined as absolute growth >12.5 mL or relative growth >33% on follow-up CT. To ensure temporal precedence of the predictors relative to the outcome, the fibrinogen decline rate and D-dimer increase rate were calculated over a fixed 24-hour landmark window from the first CT-confirmed ICH (T0) to 24 h (T1). Multivariable models were adjusted for baseline fibrinogen and D-dimer levels. Logistic regression and receiver operating characteristic analyses were performed.Results
Hematoma expansion occurred in 22 patients (32.4%). The fibrinogen decline rate independently predicted expansion in multivariate analysis after adjustment for the baseline fibrinogen level (OR 1.92 per 0.1 g/L/day, 95% CI 1.35-2.74, P = 0.001), while the D-dimer increase rate did not (OR 1.07, 95% CI 0.95-1.21, P = 0.28). The AUC for the fibrinogen decline rate was 0.85, outperforming the static admission fibrinogen level (AUC 0.68) and the absolute fibrinogen nadir (AUC 0.70). The combined model achieved an AUC of 0.94 (bootstrap 95% CI 0.87-0.99). The optimal cut-off for the fibrinogen decline rate was 0.35 g/L/day (sensitivity 77.3%, specificity 80.4%).Conclusions
The dynamic fibrinogen decline rate independently predicts hematoma expansion in APL-related ICH and outperforms static admission values. Serial coagulation monitoring in the first 24 h may enable earlier identification of high-risk patients. The proposed cut-off of 0.35 g/L/day warrants prospective validation.
Related
- Clinical Characteristics and In-Hospital Course of Symptomatic Intracranial Hemorrhage After Intravenous Alteplase in Older Adults with Acute Ischemic Stroke: A Retrospective Cohort Study
- Fibrinogen Deficiency and Dysfunction in Postpartum Hemorrhage: Evidence, Thresholds, and Management Across Resource Settings
- Predicting postpartum hemorrhage in placenta accreta spectrum patients with prophylactic abdominal aorta balloon occlusion: a retrospective cohort study
- Mass Effect Score Associations in Comatose Trauma Patients With Intracranial Hemorrhage Requiring Mechanical Ventilation: A Retrospective Study.
- Head-to-head comparison of glucose-to-albumin ratio against five albumin-derived indices for predicting 28-day ICU mortality in critically ill patients with spontaneous intracerebral hemorrhage: a multicenter retrospective study.
BibTeX
@article{lai2026dynamic,
title = {{Dynamic fibrinogen decline rate outperforms static admission values in predicting hematoma expansion in APL-related intracranial hemorrhage: a retrospective cohort study.}},
author = {Wentao Lai and Jing Hu},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1956224},
url = {https://europepmc.org/article/MED/42908511},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dynamic fibrinogen decline rate outperforms static admission values in predicting hematoma expansion in APL-related intracranial hemorrhage: a retrospective cohort study.
AU - Wentao Lai
AU - Jing Hu
PY - 2026
DA - 2026/10/07
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1956224
UR - https://europepmc.org/article/MED/42908511
AB - Background Intracranial hemorrhage (ICH) is the leading cause of early death in acute promyelocytic leukemia (APL). Current risk assessment relies on static coagulation parameters at admission, but APL-associated coagulopathy evolves rapidly. Whether dynamic changes in coagulation markers predict hematoma expansion remains unknown.Objective To determine whether the fibrinogen decline rate and D-dimer increase rate predict hematoma expansion in APL-related ICH, and to compare their predictive performance with static admission values.Methods This single-center retrospective cohort study included 68 APL patients with spontaneous ICH. Hematoma expansion was defined as absolute growth >12.5 mL or relative growth >33% on follow-up CT. To ensure temporal precedence of the predictors relative to the outcome, the fibrinogen decline rate and D-dimer increase rate were calculated over a fixed 24-hour landmark window from the first CT-confirmed ICH (T0) to 24 h (T1). Multivariable models were adjusted for baseline fibrinogen and D-dimer levels. Logistic regression and receiver operating characteristic analyses were performed.Results Hematoma expansion occurred in 22 patients (32.4%). The fibrinogen decline rate independently predicted expansion in multivariate analysis after adjustment for the baseline fibrinogen level (OR 1.92 per 0.1 g/L/day, 95% CI 1.35-2.74, P = 0.001), while the D-dimer increase rate did not (OR 1.07, 95% CI 0.95-1.21, P = 0.28). The AUC for the fibrinogen decline rate was 0.85, outperforming the static admission fibrinogen level (AUC 0.68) and the absolute fibrinogen nadir (AUC 0.70). The combined model achieved an AUC of 0.94 (bootstrap 95% CI 0.87-0.99). The optimal cut-off for the fibrinogen decline rate was 0.35 g/L/day (sensitivity 77.3%, specificity 80.4%).Conclusions The dynamic fibrinogen decline rate independently predicts hematoma expansion in APL-related ICH and outperforms static admission values. Serial coagulation monitoring in the first 24 h may enable earlier identification of high-risk patients. The proposed cut-off of 0.35 g/L/day warrants prospective validation.
SN - 2296-858X
ER -